What is the TNM stage of the patient's lung cancer, assuming no distant metastasis (M0)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TNM Staging of Lung Cancer Based on Pathology Report

Based on the pathology report, this patient has stage IIB (T2bN0M0) lung cancer.

Determining the T Stage

The T stage is determined by the size of the primary tumor and its relationship to surrounding structures:

  • The tumor size is 4.5 cm, which falls into the T2b category (tumor >4 cm but ≤5 cm) according to the 8th edition of the TNM staging system 1
  • The pathology report indicates:
    • No visceral pleural invasion
    • No direct invasion of adjacent structures
    • No spread through air spaces (STAS)
    • Unifocal disease in the left lower lobe
    • All margins negative for invasive carcinoma (closest margin 0.8 cm)

Determining the N Stage

The N stage is determined by the presence and location of regional lymph node metastases:

  • The pathology report clearly states "All regional lymph nodes negative for tumor"
  • Ten lymph nodes were examined from multiple stations (levels 7,8,9,10, and perihilar)
  • This corresponds to N0 disease (no regional lymph node metastases) 1

Determining the M Stage

  • The question specifies "assuming no metastasis," which corresponds to M0 disease
  • M0 indicates no distant metastasis 1

Final TNM Stage

Combining these elements:

  • T2b (tumor 4.5 cm)
  • N0 (no regional lymph node involvement)
  • M0 (no distant metastasis)

According to the 8th edition TNM staging system, T2bN0M0 corresponds to stage IIB lung cancer 1.

Clinical Implications

  • Stage IIB squamous cell carcinoma has a worse prognosis than stage I disease but better than stage III or IV
  • The absence of lymph node involvement is a positive prognostic factor
  • The moderate differentiation of the tumor suggests intermediate biological aggressiveness
  • The negative surgical margins (0.8 cm from closest margin) suggest complete surgical resection was achieved

Common Pitfalls to Avoid

  1. Using outdated staging systems - always use the most current TNM edition (currently 8th edition)
  2. Misclassifying tumor size - tumors 4-5 cm are specifically T2b, not T2a or T3
  3. Overlooking the importance of adequate lymph node sampling - this case had 10 nodes examined, which is considered adequate for accurate staging
  4. Failing to recognize that the absence of visceral pleural invasion keeps this tumor from being upstaged despite its size

The patient has undergone a lobectomy with adequate lymph node sampling and achieved negative margins, which is appropriate surgical management for stage IIB disease.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.